Evidence map›Paper›PMID 39335126›Full record

ArticleCancers2024

Clinicopathologic Features of Early Gastric Cancer after

Hajime Teshima, Takahiro Kotachi, Toshio Kuwai, Akiyoshi Tsuboi, Hidenori Tanaka, Ken Yamashita, Hidehiko Takigawa, Yoshihiro Kishida, Yuji Urabe, Shiro Oka

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hajime TeshimaDepartment of Gastroenterology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Takahiro KotachiDepartment of Gastroenterology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Toshio KuwaiGastrointestinal Endoscopy and Medicine, Hiroshima University Hospital, Hiroshima 734-8551, Japan.ORCID 0000-0001-9956-1358
Akiyoshi TsuboiDepartment of Gastroenterology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Hidenori TanakaDepartment of Gastroenterology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.ORCID 0000-0002-3646-5796
Ken YamashitaDepartment of Gastroenterology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Hidehiko TakigawaDepartment of Gastroenterology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.ORCID 0000-0001-6369-0641
Yoshihiro KishidaDepartment of Gastroenterology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.ORCID 0000-0002-5068-6990
Yuji UrabeDepartment of Gastroenterology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Shiro OkaDepartment of Gastroenterology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesEradication therapy for

methodsOverall, 379 patients with a total of 448 GCAE lesions treated with endoscopic resection or surgery at our hospital between January 2015 and December 2021 were assessed, and 315 patients with a known interval from eradication to diagnosis of GCAE with a total of 354 lesions were included. We classified the cases into two groups: differentiated-type GCAE (D-GCAE; 279 patients, 318 lesions) and undifferentiated-type GCAE (UD-GCAE; 36 patients, 36 lesions).

resultsSmoking and a mild-to-moderate degree of atrophy were risk factors associated with differentiated-type gastric cancer occurring more than 10 years after

Indexed as

chronic gastritisgastric cancergastric cancer discovered after eradicationHeliobacter pylori eradicationlate onset vs. early onset

Identifiers

PMID39335126
PMCPMC11429991

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.